Login / Signup

Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial.

Antonio J Zalacain-VicuñaCarlos NietoJordi PicasHelena MartínezRafael BermejoAdrián CorralesFrancisco Fernández CamposSoledad Anguiano IgeaFrancisco Javier Otero-EspinarVicente García-Patos Briones
Published in: Mycoses (2022)
A new water-soluble formulation for a ciclopirox nail lacquer showed similar efficacy to the reference product to eradicate toenail onychomycosis and superiority in the mycological cure, thus preventing reinfections and recurrences. Efficacy and safety data demonstrate the positive benefit-risk profile of this new topical antifungal preparation.
Keyphrases
  • clinical trial
  • water soluble
  • open label
  • double blind
  • study protocol
  • electronic health record
  • drug delivery
  • candida albicans
  • big data
  • randomized controlled trial
  • phase iii